Paymentus Holdings Gains After JPM Launches Digital Bill Payment

Jack Ma Sighted In Hong Kong After Almost A Year

Jack Ma, the founder of electronic e-retail giant Alibaba Inc. (BABA), was seen for the first time in Hong Kong in almost a year on Tuesday, Reuters reported.

The billionaire went completely missing from the public eye after his scathing criticism of the Chinese financial regulators in October 2020. Alibaba was under investigation for monopolizing the industry.

Ma’s company was soon to float a digital payment company named Ant Group which was ready to get listed in the Chinese exchange. In his address to the audience, Ma criticized the Chinese authorities for operating with a “pawn shop mentality.” He went so far as to compare the governance of the country with operating an airport with the skills of handling a railway station. Unsurprisingly, this did not sit well with authorities. The government cracked down on the company and Ant Group’s hopes of getting a blockbuster $37 billion public offering to go public was shelved.

The company was fined a humongous $2.75 billion by the Chinese financial authority on April 10 for employing monopolistic practices. He did appear in multiple conventions in mainland China but never in Hong Kong.

In January, almost after three months after his complete disappearance, he appeared in a video interview with some teachers. Ma also visited Alibaba’s HQ at Hangzhou in May on Ali Day. The outspoken billionaire was also spotted in eastern Zhejiang province, the HQ of Ant Group. On Wednesday, he met some of his business partners, according to reports.

Sensex rises over 200 points in early trade; Nifty above 18,240

The 30-share index was trading 207.09 points or 0.34% higher at 61,130.59 in initial deals

Equity benchmark Sensex jumped over 200 points in opening trade on October 22, tracking gains in index heavyweights HDFC twins, Titan and Bajaj Auto amid a largely positive trend in global markets.

The 30-share index was trading 207.09 points or 0.34% higher at 61,130.59 in initial deals. Similarly, the Nifty advanced 65.65 points or 0.36% to 18,243.75.

HDFC was the top gainer in the Sensex pack, rising about 2%, followed by Titan, PowerGrid, Bajaj Auto, HDFC Bank and Bharti Airtel.

On the other hand, NTPC, Infosys, HCL Tech, Tata Steel and Bajaj Finance were among the laggards.

In the previous session, the 30-share index ended 336.46 points or 0.55% lower at 60,923.50, and Nifty dropped 88.50 points or 0.48% to 18,178.10.

Business news live | Asian markets update

Foreign institutional investors (FIIs) were net sellers in the capital market, as they offloaded shares worth ₹2,818.90 crore on October 21, as per exchange data.

Elsewhere in Asia, bourses in Hong Kong, Tokyo, Shanghai and Seoul were trading with gains in mid-session deals.

Stock exchanges on Wall Street ended on a mixed note in the overnight session.

Meanwhile, international oil benchmark Brent crude fell 0.54% to $84.15 per barrel.

Pfizer’s Covid-19 Vaccine Nearly 91% Effective In Children Ages 5 To 11

Pfizer (PFE) and BioNTech’s COVID-19 vaccine showed 90.7% efficacy against the coronavirus in a clinical trial of five to 11 year olds, according to study details released on Friday.

In the trial, three children who were vaccinated got Covid-19 compared to 16 children from the group that received placebo. In the trial, twice as many children received the vaccine as the placebo.

If the FDA approves the Emergency Use Authorization of vaccine for children between 5 and 11, the shots could begin early next month. A two-dose regimen of 10-microgram dose will be administered three weeks apart.

The FDA’s Vaccines and Related Biological Products Advisory Committee is scheduled to meet on October 26 to discuss whether to recommend the vaccine for authorization for those ages 5 to 11.

In September, Pfizer and BioNTech had submitted positive data from the Phase 2/3 trial of their COVID-19 vaccine in children 5 to <12 years of age.

The pivotal trial, which included 2,268 participants 5 to <12 years of age, demonstrated a favorable safety profile and elicited robust neutralizing antibody responses using a two-dose regimen of 10 g doses. The results were comparable to those recorded in a previous Pfizer-BioNTech study in people 16 to 25 years of age, who were immunized with 30 g doses.

The companies said the 10 g dose was carefully selected as the preferred dose for safety, tolerability and immunogenicity in children 5 to <12 years of age.

HCA Healthcare Boosts FY21 Outlook – Quick Facts

While reporting financial results for the third quarter on Friday, healthcare provider HCA Healthcare, Inc. (HCA) raised its earnings and revenue guidance for the full-year 2021.

For fiscal 2021, the company now projects earnings in a range of $17.20 to $17.80 per share on revenues between $58.7 billion and $59.3 billion.

Previously, the company expected projects earnings in a range of $13.30 to $14.30 per share on revenues between $54.0 billion and $55.5 billion.

On average, analysts polled by Thomson Reuters expect the company to report earnings of $16.93 per share on revenues of $57.62 billion for the year. Analysts’ estimates typically exclude special items.

The company’s Board of Directors also declared a quarterly cash dividend of $0.48 per share on the Company’s common stock, payable on December 29, 2021 to stockholders of record at the close of business on December 14, 2021.

Paymentus Holdings Gains After JPM Launches Digital Bill Payment

Paymentus Holdings, Inc. (PAY) shares are gaining on Friday morning trade after J.P. Morgan launched Digital Bill Payment with the support of the Paymentus platform. The digital system would help accelerate revenue realization, reduce costs and improve customer satisfaction.

Currently, shares are at $26.26, up 8.65 percent from the previous close of $14.17 on a volume of 135,518. For the 52-week period, the shares have traded in a range of $22.53-$39.23 on average volume of 171,992.